Iinkcukacha eziKhawulezayo
Ngokusekelwe kumgaqo wokubophelela okukhuphisanayo
Gcina njengoko zipakishwe kwisingxobo esitywiniweyo kwiqondo lobushushu (4-30℃ okanye 40-86℉)
I-Lateral flow chromatographic immunoassay
Ukupakishwa kunye nokuhanjiswa
| Iinkcukacha zokupakisha:Iphakheji yokuthumela ngaphandle eqhelekileyo Iinkcukacha zokuziswa: phakathi kweentsuku zokusebenza ezi-7-10 emva kokufunyanwa kwentlawulo |
Iinkcukacha
Ukufunyanwa komgangatho wovavanyo olukhawulezayo lwekhithi ye-AMRDT110
Ukufunyaniswa komgangatho wovavanyo olukhawulezayo lwekhithi ye-AMRDT110 yi-lateral flow chromatographic immunoassay yokufumanisa umgangatho wamachiza amaninzi kunye ne-metabolites yechiza kumchamo kwezi zinto zilandelayo zokuxinana:
| Uvavanyo | Isilinganisi | Ukunqunyulwa (ng/mL) |
| IAmphetamine (AMP1000) | D-Amphetamine | 1,000 |
| I-Amphetamine (AMP500) | D-Amphetamine | 500 |
| IAmphetamine (AMP300) | D-Amphetamine | 300 |
| I-Benzodiazepines (BZO300) | Oxazepam | 300 |
| I-Benzodiazepines (BZO200) | Oxazepam | 200 |
| IiBarbiturates (BAR) | Secobarbital | 300 |
| IBuprenorphine (BUP) | Buprenorphine | 10 |
| I-Cocaine (COC) | Ibenzoylecgonine | 300 |
| I-Cotinine (COT) | Ikhotinine | 200 |
| I-Methadone metabolite (EDDP) | 2-Ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine | 100 |
| I-Fentanyl (FYL) | I-Fentanyl | 200 |
| IKetamine (KET) | Ketamine | 1,000 |
| Synthetic Cannabinoid (K2 50) | I-JWH-018 5-pentanoic acid / JWH-073 4-Butanoic acid | 50 |
| Synthetic Cannabinoid (K2 200) | I-JWH-018 5-pentanoic acid / JWH-073 4-Butanoic acid | 200 |
| IMethamphetamine (mAMP1000/ MET1000) | D-Methamphetamine | 1,000 |
| IMethamphetamine (mAMP500/ MET500) | D-Methamphetamine | 500 |
| IMethamphetamine (mAMP300/ MET300) | D-Methamphetamine | 300 |
| I-Methylenedioxymethamphetamine (MDMA) | D,L-Methylenedioxymethamphetamine | 500 |
| IMorphine (MOP300/ OPI300) | Morphine | 300 |
| IMethadone (MTD) | IMethadone | 300 |
| IMethaqualone (MQL) | Methaqualone | 300 |
| Ii-opiates (OPI 2000) | Morphine | 2,000 |
| I-Oxycodone (OXY) | I-Oxycodone | 100 |
| Phencyclidine (PCP) | Phencyclidine | 25 |
| Ipropoxyphene (PPX) | Ipropoxyphene | 300 |
| I-Tricyclic Antidepressants (TCA) | Nortriptyline | 1,000 |
| INtsangu (THC) | I-11-nor-Δ9-THC-9-COOH | 50 |
| Tramadol (TRA) | Tramadol | 200 |
Ulungelelwaniso lweKhiti yovavanyo olukhawulezayo lokufumanisa i-Quality i-AMRDT110 inokubandakanya nayiphi na indibaniselwano yolu hlalutyi lwamachiza ludweliswe ngasentla.
[UMGAQO]
Uvavanyo olukhawulezayo lokufumanisa i-Quality i-AMRDT110 luvavanyo lwe-immunoassay olusekelwe kumgaqo wokuzibophelela okukhuphisanayo.Amachiza anokuthi abekhona kumzekelo womchamo akhuphisana ngokuchasene neyeza lawo elidityanisiweyo kwiindawo ezibophelelayo kwi-antibody ethile.
Ngexesha lovavanyo, i-specimen yomchamo ifudukela phezulu ngesenzo se-capillary.Ichiza, ukuba likhona kumzekelo womchamo ongaphantsi koxinaniso lwalo olusikiweyo, aliyi kuzalisa iisayithi ezibophelelayo ze-antibody ethile.I-antibody iya kuthi emva koko isabele nge-conjugate ye-chiza-protein kwaye umgca ombala obonakalayo uya kubonakala kwindawo yovavanyo lomgca weyeza elithile.Ubukho bechiza ngaphezulu koxinaniso olusikiweyo buya kugcwala zonke iisayithi ezibophelelayo ze-antibody.Ngoko ke, umgca onemibala awuyi kubumba kwingingqi yovavanyo.
Umzekeliso womchamo onechiza awusayi kuvelisa umgca onemibala kwindawo ethile yovavanyo lomtya ngenxa yokhuphiswano lwamachiza, ngelixa umboniso womchamo ongenalo ichiza uya kuvelisa umgca kwindawo yovavanyo ngenxa yokungabikho kokhuphiswano ngamachiza.
Ukuze usebenze njengolawulo lwenkqubo, umgca onemibala uya kuhlala ubonakala kwindawo yolawulo, ebonisa ukuba umthamo ofanelekileyo we-specimen wongeziwe kwaye i-membrane wicking yenzeke.
